Davis Polk & Wardwell LLP has advised the joint book-running managers and representatives of the underwriters. Goodwin Procter LLP has served as outside intellectual property counsel...
Tenaya Therapeutics Completes $60 Million Units Offering
Distalmotion Secures $150 Million Series G Financing Led by Revival Healthcare Capital
Wilson Sonsini Goodrich & Rosati and Bär & Karrer have advised Revival Healthcare Capital on the deal. Walder Wyss has advised Distalmotion. Distalmotion SA, a global...
Microchip Technology’s $1.48 Billion of Depositary Shares
Wilson Sonsini Goodrich & Rosati represented Microchip Technology on the transaction, and Davis Polk & Wardwell represented the underwriters. Microchip Technology Incorporated (MCHP) completed a mandatory...
Microchip Technology’s $2 Billion Investment Grade Notes Offering
Wilson Sonsini Goodrich & Rosati advised Microchip on the transaction, and Simpson Thacher & Bartlett represented the underwriters. Microchip Technology Incorporated (Microchip) priced an offering of...
Takeda’s $75 Million Investment in Ascentage Pharma
Wilson Sonsini Goodrich & Rosati acted as the U.S. and Hong Kong counsel to Ascentage Pharma in the transaction. Ascentage Pharma Group International (Ascentage Pharma) (6855.HK)...
Tenaya Therapeutics’ $75 Million Shares Offering
Wilson Sonsini Goodrich & Rosati advised Tenaya on the deal, while Davis Polk advised the joint book-running managers and representatives of the several underwriters. Clinical stage...
Roblox’s Senior Notes Offering
Wilson Sonsini Goodrich & Rosati advised Roblox on the deal. Simpson Thacher represented Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC and J.P. Morgan...
Savara Inc.’s $130 Million Public Offering
Wilson Sonsini Goodrich & Rosati advised Savara Inc. on the deal. Savara Inc., an orphan lung disease company, announced the closing of an underwritten public offering...